CivaTech Oncology

3:15 PM - 3:30 PM (PDT), Tuesday, June 14, 2022
For over 15 years, developing and delivering the most innovative, ground breaking radiation therapy products to improve cancer care and patient outcomes. Our platforms can deliver higher radiation doses with less toxicities, broadening the spectrum of opportunity for improved cancer therapy. CivaString®, CivaSheet®, and CivaDerm™ can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products insure that radiation oncologists can deliver individualized, targeted therapy to treat cancer. Empowering the surgical and radiation oncology teams to aggressively destroy cancer!
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
CivaString, CivaSheet and CivaDerm
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Chairman and CEO
CivaTech Oncology